Sleep Number Corp Annual Deferred Income Tax Expense (Benefit) in USD from 2009 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Sleep Number Corp quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from 2009 to 2023.
  • Sleep Number Corp Deferred Income Tax Expense (Benefit) for the quarter ending March 30, 2024 was -$928K, a 71.5% increase year-over-year.
  • Sleep Number Corp annual Deferred Income Tax Expense (Benefit) for 2023 was -$12.3M, a 42.2% decline from 2022.
  • Sleep Number Corp annual Deferred Income Tax Expense (Benefit) for 2022 was -$8.65M, a 2039% decline from 2021.
  • Sleep Number Corp annual Deferred Income Tax Expense (Benefit) for 2021 was $446K.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$12.3M -$3.65M -42.2% Jan 1, 2023 Dec 30, 2023 10-K 2024-02-23
2022 -$8.65M -$9.09M -2039% Jan 2, 2022 Dec 31, 2022 10-K 2024-02-23
2021 $446K +$4.01M Jan 3, 2021 Jan 1, 2022 10-K 2024-02-23
2020 -$3.57M -$2.55M -252% Dec 29, 2019 Jan 2, 2021 10-K 2023-02-24
2019 -$1.01M -$8.46M -114% Dec 30, 2018 Dec 28, 2019 10-K 2022-03-01
2018 $7.45M +$5.41M +265% Dec 31, 2017 Dec 29, 2018 10-K 2020-02-25
2017 $2.04M +$3.68M Jan 1, 2017 Dec 30, 2017 10-K 2020-02-25
2016 -$1.64M -$13.6M -114% Jan 3, 2016 Dec 31, 2016 10-K 2019-02-26
2015 $11.9M +$12.2M Jan 4, 2015 Jan 2, 2016 10-K 2018-02-27
2014 -$311K -$2.35M -115% Dec 29, 2013 Jan 3, 2015 10-K 2017-02-24
2013 $2.04M -$1.46M -41.8% Dec 30, 2012 Dec 28, 2013 10-K 2016-03-01
2012 $3.5M +$660K +23.2% Jan 1, 2012 Dec 29, 2012 10-K 2015-02-27
2011 $2.84M +$487K +20.7% Jan 2, 2011 Dec 31, 2011 10-K 2014-02-21
2010 $2.35M +$20.6M Jan 3, 2010 Jan 1, 2011 10-K 2013-02-21
2009 -$18.2M Jan 4, 2009 Jan 2, 2010 10-K 2012-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.